Yahoo
OTC Markets OTCQB USD

Provectus Biopharmaceuticals, Inc. (PVCT)

0.0530 +0.0010 (+1.92%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-2,425.2340 -3,325.9910 -3,284.0910 -2,571.9780 -3,041.4720
Cash Flow from Financing Activities
3,165.1820 3,087.0060 2,747.8650 2,191.5550 1,367.8410
Cash and Cash Equivalents, End of Period
1,156.9150 251.2910 489.7260 1,026.7990 1,431.7070
Cash Flow, Supplemental
Free Cash Flow to Firm
-3,320.5780 -4,007.2280 -3,187.7290 -2,828.6860 -3,324.1890
Issuance of Capital Stock
225 850 300 0 0
Repurchase of Capital Stock
0 0 0 0 0
12/31/2022 - 1/15/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: